Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8891764 | 0.83 | ALDH1A1 (0.59) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| Benzyl N-Methylcarbamate SCHEMBL645204 | 0.83 | ALDH1A1 (0.62) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL234454 | 0.82 | LMNA (0.62) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| Benzyl N-Methylcarbamate SCHEMBL6510776 | 0.81 | ALDH1A1 (0.60) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL4808691 | 0.81 | ALDH1A1 (0.56) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL8705971 | 0.81 | ALDH1A1 (0.51) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL18620840 | 0.81 | ALDH1A1 (0.51) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL7306620 | 0.80 | LMNA (0.57) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| Benzyl N-Methylcarbamate SCHEMBL6461910 | 0.80 | ALDH1A1 (0.63) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A | |
| SCHEMBL7355501 | 0.80 | ALDH1A1 (0.63) | SMN1; SMN2LMNAALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174622-A1 | METHOD FOR PRODUCING TRI-CARBOBENZOXY-ARGININE | KANEKA CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174622-A1 | METHOD FOR PRODUCING TRI-CARBOBENZOXY-ARGININE | ARG1, ARGLU1, PRMT1 | SMN1; SMN2 4788/4885LMNA 4838/4885ALDH1A1 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.